Abstract
Pancreatic cancer is well known to have a short duration of survival after diagnosis, and to be relatively resistant to current therapies. When survival is short, quality of life (QOL) assumes great importance, and clinicians should be concerned not only with the biophysical disease process, but with the consequences of illness on the well-being of their patients. Knowledge of the demands that disease brings, not only in terms of physical threats, but also psychological and social consequences, and how the patient copes with their illness, treatment, and care, can only help greater understanding of disease and illness. Consideration of how to improve the quality as well as quantity of life is of paramount importance. It is recognized that QOL assessment is long overdue in pancreatic cancer (1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Trede M. Treatment of pancreatic carcinoma—the surgeon’s dilemma. Br J Surg 1987; 74:79,80.
Haddock G and Carter DC. Aetiology of pancreatic cancer. BrJ Surg 1990; 77:1159–1165.
Carter DC. Clinical features and management of carcinoma of the pancreas. Br J Hosp Med 1995; 54:459–464.
Ashton Key M, Hammersley S, Johnson CD. Incidence and mortality of gastric and pancreatic cancer in England and Wales 1961-1988. Gut 1991; 32:A580–A581.
Krech RL and Walsh D. Symptoms of pancreatic cancer. J Pain Symptom Manage 1991; 6:360–367.
Fontham ETH and Correa P. Epidemiology of pancreatic cancer. Surg Clin North Am, 1989; 69:551.
Slevin ML. Quality of life: philosophical question or clinical reality? Br Med J 1992; 305:466–469.
Fallowfield L. Quality of life: the missing measurement in health care. Souvenir, London, 1990.
World Health Organisation Constitution. WHO Chron 1947; 7:29.
Karnofsky DA, Abelman WH, Craver LF, et al. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948; 1:634–656.
Meeberg GA. Quality of life: a concept analysis. J Adv Nurs 1993; 18:32–38.
Quality of life and clinical trials. Lancet 1995; 346:1–2 (editorial).
Kassa S. Problems in assessing quality of life. J Cancer Care 1993; 2:100–103.
Cella DF. Quality of life: concepts and definitions. J Pain Symptom Manage 1994; 9:186–192.
Gill TM and Feinstein AR. A critical appraisal of the quality of life measurements. JAMA 1994; 272:619–626.
Streiner DL and Norman GR. Health measurement scales: a practical guide to their development and use, 2nd ed., Oxford University Press, Oxford, 1992.
Jaloweic A. Issues in using multiple measures of quality of life. Semin Oncol Nurs 1990; 6:271–277.
Hayden KA, et al. Pitfalls in quality of life assessment. Lessons from a Southwest Oncology Group breast cancer clinical trial. Oncol Nurs Forum 1993; 20:1415–1419.
Donovan K, Sanson Fisher RW, and Redman S. Measuring quality of life in cancer patients. J Clin Oncol 1989; 7:959–968.
Gill, TM. Quality of life assessment: values and pitfalls. J Royal Soc Med 1995; 88:680–682.
Watanapa P and Williamson RCN. Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg 1992; 79:8–20.
De Wys WD. Weight loss and nutritional abnormalities in cancer patients: incidence, severity and significance. Clin Oncol 1986; 5:251–261.
Kaiser MH, Barkin J, and Maclntyre JM. Pancreatic cancer: assessment of prognosis by clinical presentation. Cancer 1985; 56:397–402.
Lebovits AH and Lefkowitz M. Pain management of pancreatic carcinoma: a review. Pain 1988; 36:1–11.
Kelsen DP. Portenoy RK, Thaler HT, Niedzwiecki D, Passik SD, Tao Y, et al. Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 1995; 13:748–755.
Passik SD and Breitbart WS. Depression in patients with pancreatic carcinoma. Diagnostic and treatment issues. Cancer 1996; 78:615–626.
Faulkner A and Maguire P. Talking to cancer patients and their families. Oxford: Oxford Medical, Oxford, 1994.
Dunkel-Schatter C, Feinstein LG, Taylor SE, and Falke RL. Patterns of coping with Cancer. Health Psych 1992; 11:79–87.
Gammon J. Which way out of the crisis? Coping strategies for dealing with cancer. Professional Nurse 1993; May 488–493.
Maguire K. Improving the recognition and treatment of affective disorders in cancer patients. In: Granville-Grasson K (ed), Recent advances in psychiatry, 7th ed. Churchill Livingstone, London, 1992; 15–30.
Ishikawa O, Ohigashi H, Nakaizumi A, et al. Surgical resection of potentially curable pancreatic cancer with improved preservation of endocrine function: further evaluation of intraoperative cytodiagnosis. Hepato-gastroenterology 1993; 40:443–447.
Yasue M, Sakamoto J, Morimoto T, et al. Evaluation of the effect of pancreatic resection in advanced pancreatic cancer with special reference using hospital-free survival as a measure of quality-of-life. Jap J Clin Oncol 1995; 25:37–45.
Eypasch E, Williams JI, and Wood-Dauphinee S. Gastrointestinal quality of life index; development, validation and application of a new instrument. Br J Surg 1995; 82:216–222.
Pretre R, Huber O, Robert J, Soravia C, Egeli RA, and Rohner A. Results of surgical palliation for cancer of the head of the pancreas and periampullary region. Br J Surg 1992; 79:795–798.
Ebert M, Friess H, Beger HG, and Büchler MW. Role of octreotide in the treatment of pancreatic cancer. Digestion 1994; 55:48–51.
Bakkevold KE and Kambestad B. Palliation of pancreatic cancer: a prospective multicentre study. Eur J Surg Oncol 1995; 27:176–182.
Glimelius B, Hoffman K, Graf W, et al. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol 1995; 6:267–274.
Ballinger AB, McHugh M, Catnach SM, Alstead EM, and Clark MI. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994; 35:467–470.
Luman W, Cull A, Palmer KR. Quality of life following endoscopic stenting for malignant biliary obstruction. Abstract presented at the British Society of Gastroenterology, March, Brighton, 1996.
Lionetto R, Pugliese V, Bruzzi P, Rosso R. No standard treatment is available for advanced pancreatic cancer. Eur J Cancer 1995; 31A: 882–887.
Niezgoda HE and Pater JL. A validation study of the domains of core EORTC quality of life questionnaire. Qual Life Res 1993; 2:319–325.
Sprangers MA, Cull A, Bjordal K, Groenvold M, and Aaronson NK. The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life. Qual Life Res 1993; 2:287–295.
Ringdal GI and Ringdal K. Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res 1993; 2:129–140.
Aaronson NK, Cull A, Kassa S, and Sprangers MG, for the EORTC Study Group on Quality of Life. The EORTC modular approach to quality of life assessment in oncology: an update. In: Spiker B (ed), Quality of life and pharmoeconomics in clinical trials, 2nd ed. Raven, New York, 1995
Strauss A and Corbin J. Basics of qualitative research. Grounded theory procedures and techniques, Sage, London, 1990.
Portenoy RK. Pain and quality of life: clinical issues and implications for research. In: Tchekmedyian NS and Cella DF (eds), Quality of life in oncology practice and research, PRR Dominus, New York, 1991.
Pitt HA. Curative treatment for pancreatic neoplasms. Standard resection. Surg Clin N Am 1995; 75:891–904.
Maguire P (1985). Barriers to psychological care of the dying. Br Med J 291, 1711–1713.
Sugarbaker PH, Barosky I, Rosenberg SA, and Gianola FJ. Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery 1982; 91:17–23.
McLeod RS, Taylor BR, O’Connor BI, Greenberg GR, Jeejeebhoy KN, Royall D, and Langer B. Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg 1995; 169:179–185.
Fraser SCA. Quality of life measurement in surgical practice. Br J Surg 1993; 80:163–168.
Lichtenstein DR and Carr-Locke DL Endoscopic palliation for unresectable pancreatic carcinoma. [Review] Surg Clin N Am 1995; 75:969–988.
Palmer KR, Kerr M, Knowles G, Cull A, Carter DC, and Leonard RCF. Chemotherapy prolongs survival in inoperable pancreatic-carcinoma. Br J Surg 1994; 81:882–885.
Jessup JM, Posner M, and Hubeman M. Influence of multi-modality therapy on the management of pancreatic carcinoma. Semin Surg Oncol 1993; 9:27–32.
Waegner DJT, Punt CJA, and Wilke H. Current status and future directions in the perioperative treatment of pancreatic cancer. Ann Oncol 1994; 5(Suppl):S87–S90.
Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged: the index of ADL: a standardised measure of biological and psychosocial function. JAMA 1963; 185:914–919.
Kaplan RM, Bush JW, and Berry CC. Health status types of validity and the index of well being. Health Serv Res 1976; 11:478–507.
Deyo RA, Inui TS, Leninger JD, et al. Physical and psychological functions in rheumatoid arthritis: clinical use of a self-administered instrument. Arch Intern Med 1982; 142:879–882.
Hunt SM, Mckenna SP, McEwan J, et al. A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health 1980; 35:297–300.
Chambers LW, Sackett DL, Goldsmith CH, et al. Development and applications of an index of social function. Health Serv Res 1976; 11:430–441.
Goldberg DP and Williams P. A users guide to the general health questionnaire. Windsor NFER, nelson.
Satoris N. A WHO method for the assessment of health related quality of life. In: Walker SR and Rosser RM (eds) Quality of life assessment: key issues for the 1990s, Klewer, London, 1993; pp. 201–207.
Ware JE, Gandek B, the IQOLA Project Group. The SF-36 health survey: development and use in mental health research and the IQOLA Project. Int J Ment Health 1994; 23:49–73.
Spitzer WO, Dobson AJ, Hall J, et al. Measuring quality of life of cancer patients: a concise QL index for use by physicians. J Chron Dis 1981; 34:585–597.
Osbond ME, Lavin PT, Babyam RK, et al. Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic cell carcinoma. Lancet 1990; 335:994–998.
Schnipper H, Clinch J, McMurray A, and Levitt M. Measuring the quality of life of cancer patients the functional living index: cancer development and validation. J Clin Oncol 1984; 472–483.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Nat Cancer Inst 1993; 85:365–376.
De Haes JCJM, van Knippenberg FCE, and Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam symptom checklist. Br J Cancer 1990; 62:1034–1038.
Priestman TJ and Baum M. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Linear analogue self assessment (LASA). Lancet 1976; 7:899–901.
Cella DF, Tulskey DS, and Gray G. Functional assessment of cancer therapy (FACT) scale: development and validation of the general measure. J Clin Oncol 1993; 11:570–579.
Zung WWK. Self rating depression scale. Arch Gen Psychiatry 1965; 12:63–70.
Melzack R. The McGill pain questionnaire major properties and scoring methods. Pain 1975; 1:277.
Beck AT, Mendelson M, Mock J, et al. Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clin Psych Rev 1988; 8:77–100.
Baker F, Curbow B, and Wingward JR. Role retention and quality of life of bone marrow transplant survivors. Soc Sci Med 1991; 32:697–704.
Morrow GR, Chiarello RJ, and Derogatis LR. A new scale for assessing patients psychological adjustment to medical illness (PAIS). Psych Med 1978; 8:605–610.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Fitzsimmons, D., Johnson, C.D. (1998). Quality of Life in Pancreatic Cancer. In: Reber, H.A. (eds) Pancreatic Cancer. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-1810-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1810-4_18
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-7294-6
Online ISBN: 978-1-4612-1810-4
eBook Packages: Springer Book Archive